tradingkey.logo
tradingkey.logo
Search

J&J's psoriasis drug shows promise against Bristol's treatment in head-to-head study

ReutersSep 17, 2025 12:15 PM
facebooktwitterlinkedin

- Johnson & Johnson JNJ.N said on Wednesday its experimental psoriasis drug showed superior skin clearance compared to Bristol Myers Squibb's BMY.N Sotyktu in two late-stage head-to-head trials.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI